(Q44801837)

6 December 2017

title

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease (English)

1 reference

6 December 2017

0 references

0 references

Tao Wang

1

1 reference

6 December 2017

Shifu Xiao

2

1 reference

6 December 2017

Yuanyuan Liu

3

1 reference

6 December 2017

Zhiguang Lin

4

1 reference

6 December 2017

Ning Su

5

1 reference

6 December 2017

Xia Li

6

1 reference

6 December 2017

Guanjun Li

7

1 reference

6 December 2017

Mingyuan Zhang

8

1 reference

6 December 2017

Yiru Fang

9

1 reference

6 December 2017

language of work or name

English

0 references

publication date

7 December 2013

1 reference

International Journal of Geriatric Psychiatry

6 December 2017

published in

1 reference

6 December 2017

volume

29

1 reference

6 December 2017

issue

7

1 reference

6 December 2017

page(s)

713-719

1 reference

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

6 December 2017

cites work

1 reference

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

21 January 2018

1 reference

Cytokines in Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes

21 January 2018

1 reference

Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline.

21 January 2018

1 reference

Blood-based protein biomarkers for diagnosis of Alzheimer disease

21 January 2018

1 reference

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study

21 January 2018

1 reference

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients

21 January 2018

1 reference

Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease

21 January 2018

1 reference

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study

21 January 2018

1 reference

Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.

21 January 2018

1 reference

Mild cognitive impairment, amnestic type: an epidemiologic study.

21 January 2018

1 reference

Total and phosphorylated tau protein as biological markers of Alzheimer's disease

21 January 2018

1 reference

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey

21 January 2018

1 reference

Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease

21 January 2018

1 reference

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

21 January 2018

1 reference

Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease

21 January 2018

1 reference

Current concepts in mild cognitive impairment

21 January 2018

1 reference

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

21 January 2018

1 reference

Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease

21 January 2018

1 reference

Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia.

21 January 2018

1 reference

Inflammatory markers in AD and MCI patients with different biomarker profiles.

21 January 2018

1 reference

Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients.

21 January 2018

1 reference

Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease

21 January 2018

1 reference

Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease

21 January 2018

1 reference

Inflammatory markers and cognition in well-functioning African-American and white elders

21 January 2018

1 reference

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

21 January 2018

1 reference

Prevalence of dementia and major dementia subtypes in the Chinese populations: a meta-analysis of dementia prevalence surveys, 1980-2010.

21 January 2018

1 reference

Microvascular injury and blood-brain barrier leakage in Alzheimer's disease

21 January 2018

1 reference

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/GPS.4053

1 reference

6 December 2017

1 reference